Literature DB >> 11531919

Somatic and germline mutations of the TSH receptor and thyroid diseases.

B Corvilain1, J Van Sande, J E Dumont, G Vassart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11531919

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  23 in total

1.  Subclinical nonautoimmune hyperthyroidism in a family segregates with a thyrotropin receptor mutation with weakly increased constitutive activity.

Authors:  Eijun Nishihara; Chun-Rong Chen; Takuya Higashiyama; Yumiko Mizutori-Sasai; Mitsuru Ito; Sumihisa Kubota; Nobuyuki Amino; Akira Miyauchi; Basil Rapoport
Journal:  Thyroid       Date:  2010-10-07       Impact factor: 6.568

2.  Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptor.

Authors:  Chris J van Koppen; Marcel E de Gooyer; Willem-Jan Karstens; Ralf Plate; Paolo G M Conti; Tanja A E van Achterberg; Monique G A van Amstel; Jolanda H G M Brands; Jesse Wat; Rob J W Berg; J Robert D Lane; Andre M M Miltenburg; C Marco Timmers
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  Research resource: Update and extension of a glycoprotein hormone receptors web application.

Authors:  Annika Kreuchwig; Gunnar Kleinau; Franziska Kreuchwig; Catherine L Worth; Gerd Krause
Journal:  Mol Endocrinol       Date:  2011-02-03

Review 4.  G protein-coupled receptors: mutations and endocrine diseases.

Authors:  Gilbert Vassart; Sabine Costagliola
Journal:  Nat Rev Endocrinol       Date:  2011-02-08       Impact factor: 43.330

5.  Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutations.

Authors:  Marilena Celano; Marialuisa Sponziello; Giovanni Tallini; Valentina Maggisano; Rocco Bruno; Mariavittoria Dima; Enrico Di Oto; Adriano Redler; Cosimo Durante; Rosario Sacco; Sebastiano Filetti; Diego Russo
Journal:  Endocrine       Date:  2012-07-20       Impact factor: 3.633

6.  Thyrotropin (TSH) receptor residue E251 in the extracellular leucine-rich repeat domain is critical for linking TSH binding to receptor activation.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2010-02-24       Impact factor: 4.736

7.  Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor.

Authors:  Ann-Karin Haas; Gunnar Kleinau; Inna Hoyer; Susanne Neumann; Jens Furkert; Claudia Rutz; Ralf Schülein; Marvin C Gershengorn; Gerd Krause
Journal:  Cell Mol Life Sci       Date:  2010-07-22       Impact factor: 9.261

8.  Similarities and differences in the phenotype of members of an Italian family with hereditary non-autoimmune hyperthyroidism associated with an activating TSH receptor germline mutation.

Authors:  F Arturi; E Chiefari; S Tumino; D Russo; S Squatrito; G Chazenbalk; L Persani; B Rapoport; S Filetti
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

9.  The DREAM protein is associated with thyroid enlargement and nodular development.

Authors:  Marcos Rivas; Britt Mellström; Begoña Torres; Gaetano Cali; Alfonso M Ferrara; Daniela Terracciano; Mariastella Zannini; Gabriella Morreale de Escobar; Jose R Naranjo
Journal:  Mol Endocrinol       Date:  2009-03-19

10.  Increasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markers.

Authors:  Jean-Fred Fontaine; Delphine Mirebeau-Prunier; Mahatsangy Raharijaona; Brigitte Franc; Stephane Triau; Patrice Rodien; Olivier Goëau-Brissonniére; Lucie Karayan-Tapon; Marielle Mello; Rémi Houlgatte; Yves Malthiery; Frédérique Savagner
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.